I Do Not See It, But My Brain Knows What It Means
Patients suffering from "hemineglect" cannot attend to, and hence cannot see, things presented to their left side. However, sometimes these ignored stimuli may be processed without awareness.
New EC-Funded Effort To Create A Sustainable Infrastructure For Biological Data Launched
The European Commission has awarded 4.5 million euros to a pan-European consortium to decide upon the best way to unite Europe's biological data resources into a sustainable, integrative bioinformatics network for the life sciences.
Appealing The Death Sentence For Brain Cells
A new drug candidate discovered by Tel Aviv University researcher Prof. Illana Gozes may lead to an effective treatment against the debilitative Alzheimer's disease. This compound could also treat a number of diseases where patients suffer from cognitive deficits, such as schizophrenia and Parkinson's, by limiting damage to the brain.
About 60 Clinical Studies Regarding Schering-Plough's Oncology Compounds Will Be Presented At ASCO
Schering-Plough Corporation (NYSE: SGP) announced that about 80 posters, poster discussions, and oral presentations from about 60 clinical studies relating to its growing oncology franchise will be presented at the upcoming 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30 - June 3.
Human Genome Sciences Initiates First Clinical Trial Of Lead IAP Inhibitor HGS1029 In Advanced Solid Tumors
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that it has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced solid tumors.
Cancer Drug's Effectiveness Tracked Using Fireflies' Glow
The gene that allows fireflies to flash is helping researchers track the effectiveness of anti-cancer drugs over time.UT Southwestern Medical Center researchers are among the first to show that a technique called bioluminescence imaging (BLI) can be used to determine the effectiveness of cancer drugs that choke off a tumor's blood supply.
Cancer Survival May Be Predicted By Quality Of Life, U-M Study Finds
Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors.
GenVec Presents Encouraging Data On TNFerade TM In Esophageal Cancer
GenVec, Inc. (Nasdaq:GNVC) presented an overview of TNFerade™ development and an update on long-term survival data from its Phase II clinical trial using TNFerade in patients with esophageal cancer at the American Society of Gene Therapy (ASGT) 11th Annual Meeting in Boston, MA.
New Method Effective In Detecting Dangerous Coronary Plaque
A significant number of patients who suffer a heart attack never have any warning signs. For many of these individuals, the source of the problem is noncalcified plaque, a buildup of soft deposits embedded deep within the walls of the heart's arteries, undetectable by angiography or cardiac stress tests - and prone to rupture without warning.
Carnegie Mellon Computer Model Reveals How Brain Represents Meaning
Scientists at Carnegie Mellon University have taken an important step toward understanding how the human brain codes the meanings of words by creating the first computational model that can predict the unique brain activation patterns associated with names for things that you can see, hear, feel, taste or smell.